More than 40% of dietary supplements may not be as effective as touted to be, after 100 products tested by Japan’s National Consumer Affairs Center (NCAC) were unable to dissolve in water within the specified time limits.
By Michael McGuffin, president, American Herbal Products Association
Questions surrounding the hemp/CBD trade, a recognition of the continued popularity of herbal supplements, and a casting a wary eye toward regulatory creep topped the list of 2019 concerns for the American Herbal Products Association.
The dietary supplement industry is a crazy quilt that marries the sublime to the ridiculous and includes players of the highest moral and intellectual standards as well as those participating in the basest grubbing for money.
By George Paraskevakos, Executive Director, International Probiotics Association
The question came to me this past year: Why do my year end reviews resonate with film titles? The simple answer is I always draw parallel situations from film to my own life’s journey; and this year’s title couldn’t be more appropriate.
Hemp-derived CBD brands Charlotte’s Web and Infinite Product Co. have both been hit with proposed class action lawsuits filed in California that allege they misled consumers by marketing their products as dietary supplements when FDA has specifically...
Nestlé Health Science China has officially inaugurated its product innovation centre in Taizhou, Jiangsu province, to beef up the firm’s portfolio of Foods for Special Medical Purposes (FSMPs) in China.
FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.
With sales of mushroom containing dietary supplements growing year-on-year by as much as 40%, and food and beverage companies getting in on the act, demand for the fungi has been “unreal”, says Jeff Chilton, President of Nammex Organic Mushroom Extracts.
The International Probiotics Association will host its fourth IPA DC Workshop with insights from a range of experts and stakeholders, including the FDA/ CFSAN, FTC, and Health Canada. The event is held in conjunction with the US Pharmacopeia.
Yesterday four trade associations representing the dietary supplement industry sent a letter to all 535 members of the US Congress urging them to make CBD a legal dietary ingredient and to give FDA the resources to regulate the sector.
As widely predicted, the plaintiff’s bar has turned its attention to the burgeoning CBD category with a series of lawsuits alleging that products contain “significantly lower levels of CBD than advertised.”
The United Natural Products Alliance has signed a Memorandum of Understanding (MOU) with the University of Arkansas for Medical Sciences, allowing industry stakeholders access to the medical school’s analytical, technical and policy expertise.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
The ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) has published a new Laboratory Guidance Document (LGD) on Saw Palmetto Extract to help industry stakeholders better identify adulterants.
Utah-based contract manufacturer Capstone Nutrition has been acquired by a private equity firm, showing there is still room for growth in the contract manufacturing sphere despite reports of overcapacity.
The US Food and Drug Administration has shut down a Tennessee dietary supplement manufacturer that allegedly has not complied with repeated orders to not unlawfully distribute unapproved new drugs, adulterated and misbranded dietary supplements and an...
FFSSC 22000 certification for UAS Laboratories LLC verifies that the Wisconsin-based probiotics player conforms to all industry-related statutory and regulatory requirements as outlined by the FSSC 22000 International Standard for Food Safety Management...
Facilities that are subject to FSMA inspections are struggling with the initial implementation of the Foreign Supplier Verification Provision of the law, new data shows. The issue is coming to a head with the first warning letter based on a FSVP failure.
Biotech firms are reaping the rewards of a project looking into foods tackling metabolic syndrome resulting in products like microalgae, omega-3 and antioxidant-infused juices and algae-derived omega 3 oil.
When Adel Villalobos first entered the nutraceutical industry, he noticed that contract manufacturers often “held brands hostage.” He started his own contract manufacturing company with a goal of being different.